## **Core Concept**
The question tests the understanding of the side effects of drugs used in glaucoma and their potential to trigger or worsen bronchial asthma. Glaucoma treatment often involves medications that can have systemic side effects, including effects on the respiratory system.

## **Why the Correct Answer is Right**
The correct answer, **Propranolol**, is a non-selective beta-blocker commonly used in the treatment of glaucoma to decrease intraocular pressure. Beta-blockers can cause bronchoconstriction by blocking beta-2 receptors in the lungs, which are responsible for dilating airways. In patients with asthma, this can precipitate an acute asthma attack. Propranolol's lack of selectivity for beta-1 over beta-2 receptors makes it particularly likely to cause bronchospasm.

## **Why Each Wrong Option is Incorrect**
- **Option A:** Pilocarpine is a muscarinic receptor agonist used in glaucoma treatment. It works by increasing the outflow of aqueous humor and is not commonly associated with bronchial asthma exacerbation.
- **Option B:** Acetazolamide is a carbonic anhydrase inhibitor used in glaucoma treatment. It works by reducing aqueous humor production and is not typically linked to asthma attacks.
- **Option D:** Latanoprost is a prostaglandin F2α analogue used to treat glaucoma. It works by increasing the uveoscleral outflow of aqueous humor and is not commonly associated with exacerbating asthma.

## **Clinical Pearl / High-Yield Fact**
A key point to remember is that **non-selective beta-blockers** like propranolol can exacerbate asthma by causing bronchoconstriction. Patients with asthma should avoid these medications if possible, and alternative treatments for glaucoma that do not affect the respiratory system should be considered.

## **Correct Answer:** . Propranolol